This document is a published patent application from the USPTO concerning AAV capsid variants and their uses. The application, filed under number 18865157 on June 1, 2023, and designated US20260085095A1, discloses compositions and methods related to adeno-associated virus capsid protein variants. The abstract indicates potential applications in preparation, use, and formulation of these variants.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signifies potential future developments and intellectual property in the biotechnology and pharmaceutical sectors, particularly concerning gene therapy vectors. Companies operating in this space should be aware of this disclosure for competitive intelligence and potential licensing or research collaborations.